about
Isoforms of p38MAPK gamma and delta contribute to differentiation of human AML cells induced by 1,25-dihydroxyvitamin D₃The Potential of Vitamin D-Regulated Intracellular Signaling Pathways as Targets for Myeloid Leukemia TherapyVitamin D: a growing perspectiveRegulation of C/EBPbeta isoforms by MAPK pathways in HL60 cells induced to differentiate by 1,25-dihydroxyvitamin D3Cooperative antitumor effects of vitamin D3 derivatives and rosemary preparations in a mouse model of myeloid leukemiaResistance to 1,25D-induced differentiation in human acute myeloid leukemia HL60-40AF cells is associated with reduced transcriptional activity and nuclear localization of the vitamin D receptor.Serum 25-hydroxyvitamin D and cancer mortality in the NHANES III study (1988-2006)Tumor suppressor p53 status does not determine the differentiation-associated G₁ cell cycle arrest induced in leukemia cells by 1,25-dihydroxyvitamin D₃ and antioxidants.The potential therapeutic benefits of vitamin D in the treatment of estrogen receptor positive breast cancer.Equivalent anticancer activities of dietary vitamin D and calcitriol in an animal model of breast cancer: importance of mammary CYP27B1 for treatment and prevention.The role of vitamin D in hematologic disease and stem cell transplantation.Role of Vitamin A/Retinoic Acid in Regulation of Embryonic and Adult Hematopoiesis.The role of vitamin D in cancer prevention and treatment.The role of vitamin D in cancer prevention and treatment.Vitamin D: metabolism, molecular mechanisms, and mutations to malignancies.Vitamin D Control of Hematopoietic Cell Differentiation and Leukemia.The role of VDR and BIM in potentiation of cytarabine-induced cell death in human AML blasts.Novel Gemini vitamin D(3) analogs have potent antitumor activity.Differentiation-inducing potency of the seco-steroid JK-1624F2-2 can be increased by combination with an antioxidant and a p38MAPK inhibitor which upregulates the JNK pathway.Regulation of Leukemic Cell Differentiation through the Vitamin D Receptor at the Levels of Intracellular Signal Transduction, Gene Transcription, and Protein Trafficking and Stability.Vitamin D: Effect on Haematopoiesis and Immune System and Clinical Applications
P2860
Q24569633-B8B96DDF-E44D-44AD-B822-A14BA2B099A4Q26799596-D15F3B2F-D00A-4B87-81AF-D9BD55C61721Q28284634-C6065F4A-C0B8-4509-8F78-DEB9FC217A37Q33622844-07C26FE6-4FCB-4958-8EB8-5B0017402D3DQ33668436-4A3D0212-4513-4172-B362-FD97A473D3A0Q33746099-63B4CED6-3CCF-4282-9E23-9417CDB0C6BCQ34281077-F404B045-DDE2-4E82-8F36-59EBB97AC5B9Q34581838-2CF38C02-54AF-4DE1-8EF4-FA78447A7AB9Q36195219-72EE7BCC-EB28-4042-889F-2441643F9718Q36561789-1EC054B7-B307-430E-B3C4-E3DDCD12709AQ37050872-B92100C8-A3A2-4554-A3F1-02E26B0D7F70Q37673265-D11CB541-9765-4FA0-A818-1B52D15D69CDQ37761548-0DD441E3-B917-4D9F-8BA0-094BA2FF8CA1Q38004753-0537E4DF-17C1-4166-9C05-5A817902912FQ38077504-0459F905-DB78-43C5-AE62-3F308EF3F73BQ39037456-9D631D30-97B1-4851-BB02-5FA168E034E4Q39796064-F89C4A47-628A-433F-B7AC-05D72B34477EQ39927117-0A65CFFF-D6B8-4CDE-B48D-B12F8060A628Q40116924-CF85602D-6D08-4CDD-B14F-6D3B09508F4CQ41957681-CED715BC-0527-44B3-BD62-EBA4BA96EDEEQ58757535-1CC8B574-EFD2-47C3-8B8D-59B516F92537
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Vitamin D compounds in leukemia.
@ast
Vitamin D compounds in leukemia.
@en
type
label
Vitamin D compounds in leukemia.
@ast
Vitamin D compounds in leukemia.
@en
prefLabel
Vitamin D compounds in leukemia.
@ast
Vitamin D compounds in leukemia.
@en
P1476
Vitamin D compounds in leukemia.
@en
P2093
H Phillip Koeffler
Quang T Luong
P304
P356
10.1016/J.JSBMB.2005.06.017
P577
2005-08-08T00:00:00Z